DRIEHAUS CAPITAL MANAGEMENT LLC

Holdings History for Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)

Symbol: CLYM on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.02%	+0.02%	$2,403,784	600,946	+600,946	NEW	$4.00	Q4 2025
31 Dec 2024		-0.03%	$0	0	-612,387	-100%	$5.61	Q4 2024
30 Sep 2024	0.03%	-0%	$3,117,050	612,387	-83,670	-12%	$5.09	Q3 2024
30 Jun 2024	0.05%	-0.01%	$4,948,965	696,057	-115,623	-14%	$7.11	Q2 2024
31 Mar 2024	0.02%	0%	$2,224,003	811,680	0		$2.74	Q1 2024
31 Dec 2023	0.03%	0%	$2,191,536	811,680	0		$2.70	Q4 2023
30 Sep 2023	0.03%	+0%	$2,134,718	811,680	+1,087	+0.13%	$2.63	Q3 2023
30 Jun 2023	0.03%	+0%	$2,269,660	810,593	+136,909	+20%	$2.80	Q2 2023
31 Mar 2023	0.03%	+0%	$1,953,684	673,684	+121,742	+22%	$2.90	Q1 2023
31 Dec 2022	0.03%	+0.01%	$2,025,627	551,942	+203,371	+58%	$3.67	Q4 2022
30 Sep 2022	0.02%	+0.02%	$1,126,000	348,571	+348,571	NEW	$3.23	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.